FORTA-Liste empfiehlt Gliptine
Crossref DOI link: https://doi.org/10.1007/s42090-017-0025-7
Published Online: 2017-09-18
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stiefelhagen, Peter
